No actions available.

Full Text of this Amendment

SA 1042. Mr. ENSIGN submitted an amendment intended to be proposed by him to the bill S. 1082, to amend the Federal Food, Drug, and Cosmetic Act to reauthorize and amend the prescription drug user fee provisions, and for other purposes; which was ordered to lie on the table; as follows:

At the appropriate place, insert the following:
A healthcare provider who prescribes, or who dispenses pursuant to a prescription, a drug, biologic product, or medical device approved, licensed, or cleared by the Food and Drug Administration shall not be named as a party to a product liability lawsuit involving such drug, biological product, or medical device and shall not be liable to a claimant in a class action lawsuit against the manufacturer, distributor, or seller of such drug, biological product, or medical device.

(As printed in the Congressional Record for the Senate on May 3, 2007.)